FMC CORP FMC revenue by segment, product and geography
In its fiscal year ending 2025-12-31, FMC CORP reported revenue across 5 products and services; the largest, Insecticides, was $1.57B, 45.4% of the filed sum (-33.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Insecticides$1.57B45.4%-33.9% yoy
- Herbicides$1.25B36.0%-2.6% yoy
- Fungicides$363M10.5%+2.9% yoy
- Plant Health$191M5.5%-4.8% yoy
- Product And Service Other$94.1M2.7%+171.2% yoy
Members sum to the consolidated $3.47B for this period.
- Latin America$1.35Bshare n/a-2.7% yoy
- Brazil$1.12Bshare n/a+3.3% yoy
- North America$1.1Bshare n/a-6.1% yoy
- United States$923Mshare n/a-8.0% yoy
- EMEA$872Mshare n/a+4.4% yoy
- Asia$142Mshare n/a-83.2% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Insecticides$424M48.8%-19.4% yoy
- Herbicides$318M36.7%-15.4% yoy
- Fungicides$88.4M10.2%+10.0% yoy
- Plant Health$36.3M4.2%-19.2% yoy
- Product And Service Other$700K0.1%-97.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.